In advance of the Strategies for an HIV Cure meeting, AVAC is hosting a foundational training for lay audiences interested in building their knowledge of HIV cure research. Through interactive sessions led by leading experts in the field, the meeting will provide attendees the ability to understand and translate basic science information.
The program will feature: Janet Siliciano, Deborah Persaud, Steven Deeks, Rebecca Lynch and David Margolis.
A breakdown of current HIV mRNA trials and a primer on the basics of mRNA technology.
Avac Event
DoxyPEP Implementation – All Systems Go?
On October 5, The Choice Agenda (TCA) and the National Coalition of STD Directors (NCSD) hosted a discussion on the roll out of Doxycycline as STI PEP for helping gay, bisexual, and other men who have sex with men and transgender women reduce bacterial STIs, including gonorrhea, chlamydia, and syphilis.
Speakers:
Dr. Taimur Khan, Fenway Health Cait Shea, NCSD Kendrick Clack, NP, Crofoot MD Clinic/Research Center Lee Vaughn-Ogin, Bigger Blacker Book
DPP Audience & Provider Insights for the DPP Research and Marketing Plan: Phase 1 Research Findings
This report, by M&C Saatchi World Services, AVAC, and partners, highlights learnings from Human-Centered Design Research undertaken in 2022 to understand the values and motivations of potential users and influencers of the Dual Prevention Pill (DPP) in Kenya, South Africa, and Zimbabwe.
Frequently Asked Questions About the Dual Prevention Pill (DPP)
This factsheet provides answers to the most frequently asked questions about the Dual Prevention Pill (DPP), including what it is, who might use it, and how it can be rolled out.
The updated AVAC.org also reflects the expanded vision and practice of our dynamic programs. AVAC will always work to accelerate ethical development and equitable delivery of effective HIV prevention options. But, we also know that responding to HIV and preparing for future pandemics requires a comprehensive, integrated, and sustained response that is rights-based, people-centered and evidence-informed.
To AVAC, this means connecting the dots between HIV prevention, sexual and reproductive health and rights, pandemic preparedness, strengthened health systems, research engagement and community leadership. It means recognizing that resilience in global health requires us to confront the threats posed by disparities in access, entrenched stigma, discrimination, criminalizing key populations and inadequate responses to other sexually transmitted infections.
Visit the new AVAC.org for resources, tools and analysis that make these connections as we continue to track and translate the field, including:
Information on the entire pipeline of biomedical prevention strategies being investigated today
Our projects, which showcase the incredible partnerships and collaboration that underpin everything we do
Our podcast, PxPulse, which will deepen your knowledge and help you “check the pulse” of this fast-paced field and the urgent challenges still ahead
PxWire our quarterly update on where we are in biomedical prevention research
Our HIV clinical trials database, where you can find details on all biomedical prevention trials and our broader resource database containing fact sheets, infographics, blog posts and more on HIV prevention and the broader issues surrounding global health equity
We are immensely proud to share these resources with you. We hope these tools and analyses will help to power your advocacy, accelerate ethical development and equitable delivery of effective HIV prevention options, and advance global health equity.
Px Wire May 2023
Volume 13, Number 2
PrEP Tracker data, preparing for new products, the HIV prevention pipeline and our prevention playlist. All that and more in the latest issue of PxWire.
Sexually Transmitted Infections
An Introductory Fact Sheet
This factsheet provides basic information on sexually transmitted infections (STIs), and a snapshot on the global status of STIs in the context of HIV prevention and global health equity.
Avac Event
How do People Who Use/Inject Drugs Intersect with PrEP Research and Service Delivery?
On Wednesday, September 6, please make plans to join The Choice Agenda (TCA), the International Network of People Who Use Drugs (INPUD) and our wonderful expert speakers to discuss the health and wellness priorities of people who use/inject drugs, and how these communities (“key populations”) intersect across PrEP research, development, and implementation activities. They will highlight critical gaps in the PrEP agenda, underscore opportunities for improvement, and share strategies for better inclusion, representation and meaningful engagement.
Speakers: John Kimani, Kenya Network of People Who Use Drugs (KeNPUD) Dr. Sunil Solomon, Johns Hopkins University, Ukrainian Provider
** With special thanks to WHO, this webinarwill offer simultaneous Ukrainian translation. **
Tales from Two Cities: HIV and STI research highlights from Brisbane and Chicago
August 3, 2023 at 9am ET
TCA’s invited experts will share their highlights and reflections on the HIV and STI-related science presented at two major global health conferences. These conferences include IAS 2023, taking place in Brisbane, Australia July 23 – 26 and the 2023 STI and HIV World Congress happening in Chicago (United States) from July 24 – July 27.
Speakers include: Dr. Aniruddha Hazra – University of Chicago Nyaradzo M Mgodi – University of Zimbabwe Roger Pebody – NAM, Aidsmap.com Charlie Peterson – University of Illinois – Chicago
